Members of the NHMRC Council, 2015-2018 triennium

Bruce Robinson

Chair,
Professor
Bruce
Robinson

Professor Bruce Robinson is an endocrinologist. He is Chair of the Australian Government’s Taskforce of expert clinicians charged with reviewing the Medicare Benefits Schedule and in 2015 was appointed as Chair of Australia’s peak advisory and funding body for medical research, National Health and Medical Research Council.

Professor Robinson’s research has focused on identifying genetic changes which either predispose or directly cause endocrine tumours. Other highlights include the formation of an international consortium of families from around the world to study medullary thyroid carcinoma and phaeochromocytoma. He has been head of the Cancer Genetics Unit at the Kolling Institute of Medical Research, Royal North Shore Hospital, since 1989. He continues to practice at Sydney’s Royal North Shore Hospital.

Professor Robinson was the Dean of Sydney Medical School from 2007 until 2016. Since 2001, he has been Chairman of Hoc Mai Foundation, a major program in medical and health education and exchange with Vietnam.

Professor Robinson has supervised 37 PhD students and has more than 300 research publications.

Declaration

  • Board Member MaynePharma and shareholder
  • Board Member Cochlear
  • Board Member Woolcock Institute
  • Advisory Board Member Astra Zeneca, Bayer and Eisai
  • Minter Ellison consultant
  • Qbiotics Board Member and shareholder
  • Firefly Board Member and Shareholder
Kathryn North

Professor
Kathryn
North

Professor Kathryn North is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor North is trained as a paediatric physician, neurologist and clinical geneticist.

Her laboratory research interests focus on the inherited muscle disorders. Her clinical research focuses on clinical trials of therapies for muscular dystrophy as well as the development of interventions for children with learning disabilities. In 2012, Professor North was appointed Chair of the NHMRC Research Committee and Member of NHMRC Council.

Declaration

Nil apart from institutional affiliations and current NHMRC funding

Ian Olver

Professor
Ian
Olver

Professor Ian Olver, AM is the Director of the Sansom Institute for Health Research and was recently Chief Executive Officer of Cancer Council Australia. A renowned oncologist, cancer researcher and bioethicist, Ian has held senior positions in Australia and abroad.

With research interests in anticancer drug studies, symptom control, bio-ethics and psycho-oncology, Ian is the author of more than 200 journal articles and is a regular commentator on cancer issues in Australia and internationally.

Ian was appointed a Member of the Order of Australia (AM) for service to medical oncology as a clinician, researcher, administrator and mentor, and to the community through leadership roles with cancer control organisations.

Professor Olver is Chair of Australian Health Ethics Committee.

 

Declaration

  • Employed by University of South Australia
  • I hold 3 project grants and 1 partnership grant funded by NHMRC, 1 ARC linkage grant, 1 Sydney Catalyst Grant and one Cancer Australia grant. I am a CI on 3 further project grants and 2 Centre of Research Excellence Grants submitted in 2015
  • I have applied for 3 NHMRC Grants and 1 Translational Research Project.
  • I have consulted for the company Tesaro with UniSA receiving the funds.
  • I have engaged in educational activities with Teasro, Helsinn, Teva, Seqirus and Merck
Sharon Lewin

Professor
Sharon
Lewin

Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; consultant infectious diseases physician, Alfred Hospital, Melbourne, Australia; and an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellow. She is an infectious diseases physician and basic scientist. She leads a large multi-disciplinary research team that focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection.

She was the local co-chair of the International AIDS Conference (AIDS2014) which was held in Melbourne July 2014 which was the largest health conference ever held in Australia. In 2014, she was named Melburnian of the Year, an annual award from the City of Melbourne to an inspirational role model who has made an outstanding contribution to the city in their chosen field.

She is active internationally in advocating for increased investment from the public and private sector in HIV cure research and is on the leadership team of the International AIDS Society’s Strategy Towards an HIV Cure. She is a member of the Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmitted Infections, which is the peak advisory body on HIV infection to the Australian Minister of Health.

Chair of Health Translation Advisory Committee.

Declaration

  • Consultant to Tetralogic Pty Ltd, Calimmune Pty Ltd, Geovax Pty Ltd and Abivax Pty Ltd
  • I am a chief investigator on NHMRC project grants, program grant, practitioner fellowship and a partnership grant I recieve funds from the National Institutes for Health, Wellcome Trust, American Foundation for AIDS Research and University of Malaya for research projects. I have received funding to support investigator initiatied projects from Viiv Healthcare, Merck, Gilead Sciences and Tetralogic.
  • I have received honoraria paid to my institution for providing advice to Gilead Sciences and Bristol Myers Squibb
  • I have participated in advisory boards to Merck and Gilead. Payments are made to my institution
  • In the last 2 years, I have participated in educational activities organised by Viiv Healthcare, Merck and Gilead. All honoraria have been paid to my institution
Graeme Samuel

Professor
Graeme
Samuel

Professor Graeme Samuel AC is a Vice Chancellor’s Professorial Fellow in Monash University’s Business School and co-director of the Monash Business Policy Forum. He is also Chair of the Victorian Taxi Services Commission, a Commissioner of the National Rugby League, a Councillor of the Australian National University, President of Alzheimer’s Australia, and Chair of the South Eastern Melbourne Primary Health Network.

Professor Samuel has held a number of roles in public life including former Chairman of the Australian Competition and Consumer Commission. He was appointed an Officer of the Order of Australia in 1998. In 2010 he was elevated to a Companion of the Order of Australia.

Chair of Health Innovation Advisory Committee.

Declaration

  • Leadership roles in a number of not for profit institutions that have an interest in the outcomes from health and medical research.
  • A director of and family holds a minority shareholding interest in two companies (Sonoeye Pty Ltd and Mupharma Pty Ltd) that are involved in medical research and may benefit from grants made by the NHMRC.
Brendan Murphy

Professor
Brendan
Murphy

Professor Brendan Murphy is the Chief Medical Officer for the Australian Government and is the principal medical adviser to the Minister and the Department of Health. He also holds direct responsibility for the Department of Health’s Office of Health Protection. 

 Apart from the many committees he chairs, co-chairs and participates, he is the Australian Member on the International Agency for Research on Cancer (IARC) Governing Committee and represents Australia at the World Health Assembly.

Prior to his appointment Professor Murphy was the Chief Executive Officer of Austin Health in Victoria.

Declaration

Board Member Centenary Institute of Cancer Medicine and Cell Biology

Kerry Chant

Dr
Kerry
Chant PSM

Dr Chant is a Public Health physician, Chief Health Officer for New South Wales and Deputy Director-General, Population and Public Health, NSW Health. Prior to this she was Director, Health Protection and Deputy Chief Health Officer, NSW Health.

Dr Chant has extensive public health experience, having held a range of senior positions in New South Wales public health units since 1991. She has a particular interest in blood-borne virus infections, communicable disease prevention and control, and Indigenous health.

Declaration

  • NSW Ministry of Health
  • I own shares in Wesfarmers & Telstra
  • Member of AFPHM
Charles Guest

Professor
Charles
Guest

Professor Charles Guest is presently Chief Health Officer Victoria.  He has  worked in government and academic public health medicine in Australia and overseas, and as Chief Health Officer in the Australian Capital Territory in 2005 and 2007-11. He originally trained at the University of Melbourne.

He has academic appointments at University of Melbourne, Monash University and the Australian National University. 

Declaration

Shares in CSL Salary Victorian Department of Health and Human Services Fellow Australasian Faculty of Public Health Medicine

Jeannette Young

Dr
Jeannette
Young PSM

Dr Young has been the Chief Health Officer for Queensland since August 2005. Prior to this she held the position of Executive Director of Medical Services at the Princess Alexandra Hospital in Brisbane and previously worked in a range of positions in Queensland and Sydney. Her clinical background is in emergency medicine.

Dr Young has specialist qualifications as a Fellow by Distinction of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom. She is an adjunct professor at Queensland University of Technology and at Griffith University.

Dr Young is a member of numerous state and national committees and boards, including the Council of the QIMR Berghoffer Medical Research Institute, the Australian Health Protection Principal Committee and the Australian National Preventive Health Agency Advisory Council.

Declaration

  • Member of QIMR Berghoffer Council
  • Chief Health Officer of Queensland
  • A family member has previously received NHMRC funding and may apply for funding in the future
  • Funding received as an investigator for a grant into Hendra research
  • Senior Executive In Queensland Department of Health with responsibility for the Office of Medical Research
  • Adjunct Professor at Queensland University of Technology
  • Adjunct Professor at Griffith University
Paddy Phillips

Professor
Paddy
Phillips PSM

Professor Phillips is Chief Medical Officer for South Australia. He was previously Chair of the South Australian Clinical Senate, Chair of the South Australian State-wide Clinical Network in Cardiology, and Professor and Head of Medicine, Flinders University, Flinders Medical Centre and Repatriation General Hospital, Adelaide.

Before that Professor Phillips held senior clinical academic posts at the University of Melbourne, followed by Oxford University. His interests are in building a better health system through innovation, collaboration and leadership. He remains clinically active in acute general medicine.

Declaration

  • Family member has sat on, and I think continues to sit on, pharmaceutical company advisory boards in the area of diabetes and endocrinology. I do not know which ones
  • I am employed by both Flinders University and SA Health.
  • Family member has a share portfolio but I do not know what is in it that relates to the biomedical and health sciences sector.
Gary Geelhoed

Professor
Gary
Geelhoed

Chief Medical Officer; Assistant Director General – Clinical Services and Research – WA Health

Professor Gary Geelhoed is a Paediatric Emergency Physician who received his qualifications locally at the University of WA.

Prior to commencing as Chief Medical Officer, Professor Geelhoed worked as Director of the Emergency Department at Princess Margaret Hospital for Children for 21 years.

He is a past President of the Australian Medical Association WA, and current Federal and Western Australian AMA Councillor.

Professor Geelhoed’s main research interest lies in acute respiratory illness in children.

Declaration

Member of:

  • AMA Federal Council
  • AMA Medical Workforce Committee
  • AHMAC Hospitals Principal Committee
  • Clinical Trials Advisory Committee
  • National Blood Authority’s Jurisdictional Blood Committee
  • Nationally Funded Centres Reference Group
  • Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Working Group
  • WA Health Translation Network Board
Anthony Lawler

Professor
Anthony
Lawler

TAS Chief Medical Officer, Anthony is the Director of Acute Health Services Planning and Design within the Department of Health and Human Services. He is also Professor in Health Services at the University of Tasmania and a member of the Australian Medical Council’s Special Education Accreditation Committee. He was previously the Medical Advisor to the Minister for Health, Deputy Head of the Tasmanian School of Medicine and Tasmanian Branch President of the Australian Medical Association.

Anthony is a practising Specialist Emergency Physician and Director and President-Elect of the Australasian College for Emergency Medicine. He is a Director of HealthDirect Australia, and of the Postgraduate Medical Education Council of Tasmania.

 

Declaration

  • Involved in development of and accreditation against training and clinical policy standards for emergency practice across Australia and New Zealand
  • Corporate and clinical governance responsibility for large COAG-initiated organisation providing strategic sourcing and contract management in telephony and digital health service offerings
  • Provide advice to the Directors of the AMC on the accreditation of specialist training providers (Specialist Colleges)
  • Responsible for acute purchasing strategies, clinical governance, medical workforce strategy, emergency preparedness and advice on complex ethical and clinical issues.
Paul Kelly

Dr
Paul
Kelly

Dr Kelly is a public health physician, Chief Health Officer for the ACT and Executive Director of Population Health, ACT Government Health Directorate. He is an adjunct professor at the Australian National University and at the University of Canberra. He has worked in government and academic public health in four Australian jurisdictions and in several other countries. He is a member of two World Health Organization committees.

Dr Kelly has a particular research interest and expertise in respiratory infectious diseases, including tuberculosis and influenza, health services research and systems approaches to chronic disease prevention.

Declaration

  • ACT Health-employment
  • ANU - adjunct appointment.
Hugh Heggie

Dr
Hugh
Heggie

Dr Hugh Heggie currently is the Chief Health Officer for the NT Department of Health and is a member of the Executive Leadership Team. He has representational roles in a number of national committees and advisory groups around public health, health protection and prevention as well as governance, safety and quality, indigenous health, digital health, health workforce and research to mention some. His current portfolio includes Centre for Disease Control, Environmental Health, the Medical Education and Training Centre and has been deeply involved in digital health reforms across the NT.  

Having been a pharmacologist previously Dr Heggie has been a rural generalist practitioner, with advanced skills in obstetrics and emergency medicine, since 1980 and has worked in remote settings in the Northern Territory as a resident Rural Medical Practitioner since 2002, in both Central Australia and the Top End, joining the NT Department of Health Remote Health branch in 2009 in the Chronic Disease portfolio.  He was appointed as the Senior Rural Medical Practitioner - Operations for Top End Remote Health in May 2011, Acting Chief Rural Medical Practitioner for the NT in 2013 and was the Director of Medical Services, Primary Health Care Branch, Top End Health Service up until 2016.

Declaration

  • Board Member Health Providers Alliance NT

  • Member of Digital Health Agency Clinical and Technical Committe

  • Member of Radiation Health Advisory Council (Australian Radiation Protection and Nuclear Safety Agency)

Sandra Eades

Professor
Professor Sandra
Eades

Professor Sandra is an Associate Dean (Indigenous) for the Faculty of Medicine, Dentistry and Health Sciences, Centre for Epidemiology and Biostatistics within the Melbourne School of Population and Global Health at The University of Melbourne.   Sandra, whose family are Noongar from the Minang, Goreng and Kaniyang clans in south-west Western Australia, has made outstanding contributions to the epidemiology of Indigenous child health in Australia, as well as national leadership in Indigenous health research.    In 2003, Sandra was Australia's first Aboriginal medical doctor to be awarded a Doctorate of Philosophy, at the Telethon Institute for Child Health Research, in Perth. That same year, she was recognised as NSW Woman of the Year for her work in paediatric and perinatal epidemiology, identifying links between social factors, such as housing, and infant health.    Sandra is a Fellow of the Australian Academy of Health and Medical Science.

Declaration

  • Since 2008 I have been employed by Baker IDI an independent medical research institute
  • I currently hold NHMRC project grants as an investigator
  • I have previously held a NHMRC people support grant and I am likely to hold a NHMRC people support grant in the future
  • Board Member on Outback Stores
Karen Carey

Ms
Karen
Carey

Karen Carey has represented consumers for more than a decade across all levels of the healthcare system. She is the Chair of the NHMRC Community and Consumer Advisory Group, the immediate past Chair of Consumers Health Forum and former Chair of Health Consumers Council of WA.

Karen’s focus is on building a healthcare system that highly values prevention and in which consumers can meaningfully partner with service providers to deliver safe, effective and cost-effective care, from individual patient episodes to system-wide strategic planning and design.

Declaration

  • Founder and major shareholder in Tonic Health Media Pty Ltd
  • Consumer Representative NBA Patient Blood Management Steering Committee
  • Personal Health Interest Organ Transplantation
Michael Kidd

Professor
Michael
Kidd AM

Professor Michael Kidd AM is a general practitioner, primary care researcher, medical educator and author. He is the Executive Dean of the Faculty of Medicine, Nursing and Health Sciences at Flinders University. He is the current president of the World Organization of Family Doctors and a past president of the Royal Australian College of General Practitioners. He is an elected fellow of the Australian Academy of Health and Medical Sciences.

He is a member of the Australian Therapeutic Goods Advisory Council, chair of the South Australian Government’s Clinical Training Council, and a member of the board of directors of beyondblue, Therapeutic Guidelines, Flinders Fertility, FCD Health, and the Channel 7 Children’s Research Foundation.

Declaration

  • Employed as executive dean of the Faculty of Medicine, Nursing and Health Sciences at Flinders University
  • Not for profit organisation for mental health, director fees paid
  • Not for profit medical publishing company, producing guidelines for medication management
  • Primary care service company owned by Flinders University and Charles Darwin University
  • Assisted reproductive technology company owned by Flinders University and SA Health
  • Flinders University nominee on board, not for profit charitable organisation supporting research, no director fees paid
  • Not for profit research foundation, no director fees paid
  • Employed as Professor of General Practice at University of Sydney, 1996-2009
  • Not for profit research institute for Aboriginal and Torres Strait Islander Health, Representative of Flinders University
  • Elected fellow of Australian Academy of Health and Medical Sciences
  • Australian Government funded organisation supporting medical students interested in a career in general practice
  • Australian Government funded organisation supporting doctors in training in the speciality of general practice
  • Not for profit global organisation, in collaborative relations with the World Health Organization, representing over 500,000 family doctors in over 140 countries. No director fees paid
  • Regular consultancy work with the World Health Organization. Honorarium, travel, accommodation paid
  • Medical journal published by BioMed Central/Springer, honorarium paid
  • Chief Investigator or Associate Investigator on current NHMRC grants
  • General practitioner, medical educator, primary care researcher and medical leader
David Story

Professor
David
Story

Professor David Story is Foundation Chair of Anaesthesia at the University of Melbourne; and Head of the Anaesthesia, Perioperative and Pain Medicine Unit. He promotes research, teaching and engagement at the 14 hospitals affiliated with the University. His clinical work involves perioperative care for all surgical specialties including liver transplantation.

Professor Story is a senior investigator with the Clinical Trials Network of the Australian and New Zealand College of Anaesthetists (ANZCA), sits on the ANZCA Research Committee, and is Deputy Chair of the ANZCA Safety and Quality Committee. His research is focused on effective approaches to reduce short term and long term perioperative risk, complications, disability, and mortality. He is committed to integrating research evidence and methodology into safety and quality in health care.

Declaration

Chair of Anaesthesia, The University of Melbourne  apart from institutional affiliations and current NHMRC funding

Brendan Crabb

Professor
Brendan
Crabb AC

Professor Brendan Crabb is the Director and CEO of Burnet Institute and Immediate-Past President of the Association of Australian Medical Research Institutes. Professor Crabb is a molecular biologist with a particular interest in infectious diseases and in health issues of the developing world. His personal research is the development of a malaria vaccine and the identification of new treatments for this disease. He is the current Chair of the US-based Malaria Vaccine Science Portfolio Advisory Committee, the oversight group for the major malaria vaccines under development.

He holds Professorial appointments at The University of Melbourne and Monash Universities and is a Fellow of the Australian Academy of Health and Medical Sciences.

He was awarded a Companion of the Order of Australia (AC) in the 2015 Australia Day Honours for eminent service to medical science as a prominent researcher of infectious diseases, particularly malaria, and their impact on population health in developing nations, as an advocate, mentor and administrator, and through fostering medical research nationally and internationally.

Declaration

  • Since 2008 - Employed as Director and CEO, Burnet Institute, Melbourne
  • Since 2014- Director, Board of Research Australia Ltd
  • Since 2014- Chair, Victorian Chapter of Association of Australian Medical Research Institutes (AAMRI)
  • Since 2013- Chair, Alfred Medical Research & Education Precinct Council, Victoria
  • Since 2012- Member, Scientific Advisory Board (malaria), Wellcome Trust Sanger Institute, UK. Receive support for travel and accommodation to annual meeting
  • Since 2008- Member, PATH/MVI Vaccine Science Portfolio Advisory Council (VSPAC), USA (since 2008) Receive support for travel and accommodation to annual meeting
  • Since 2012 - Member, Scientific Advisory Board, Monash Institute of Pharmaceutical Sciences (MIPS)
  • Since 2012 - Chair, Papua New Guinea Institute of Medical Research International Buttressing Coalition
  • Since 2012- Director & Immediate Past President, Association of Australian Medical Research Institutes (AAMRI)
  • Since 2010 - Director, Board of AMREP Animal Services Pty Ltd, Victoria
  • Since 2001- Member, Board of the Gene Technology Access Centre (GTAC), Victoria
  • NHMRC grants currently held by me and my group
Jonathan Carapetis

Professor
Jonathan
Carapetis

Professor Carapetis is the Director of the Telethon Kids Institute in Perth, Western Australia. He holds separate qualifications as a medical practitioner (MBBS), specialist paediatrician (FRACP Paediatrics), specialist infectious diseases physician (FRACP Infect Dis), and specialist public health physician (FAFPHM), as well as a PhD.

His research interests include Rheumatic fever and rheumatic heart disease, Other group A streptococcal diseases, Vaccine preventable disease, Indigenous child health, Child development and education, Youth health and education and Skin sores and scabies.

Previous positions include Director of the Menzies School of Health Research in Darwin, Northern Territory from 2006-2012, terms as Director of the Centre for International Child Health at the University of Melbourne, Theme Director at the Murdoch Childrens Research Institute in Melbourne and Clinical Fellow in Paediatric Infectious Diseases at the Hospital for Sick Children, Toronto, Canada. Professor Carapetis holds a clinical position with the Princess Margaret Hospital for Children and is a Professor at The University of Western Australia.

Declaration

  • Since 2012 - Employed as Director, Telethon Kids Institute, Subiaco, WA.  Not for Profit Child Health Research Institute
  • Since 2012 - Employed as Consultant Paediatrician, Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital for Children, Subiaco, WA.
  • Since 2012 - Employed as Professor, Centre for Child Health Research, The University of Western Australia, Nedlands, WA.
  • Adjunct Professor, University of Queensland
  • Honorary Professor, University of Cape Town
  • Honorary Fellow with the Murdoch Children’s Research Institute
  • Honorary Distinguished Research Fellow of the Walter and Eliza Hall Institute of Medical Research
  • Since 2015 - Member, RHDAustralia Advisory Committee (ARC); Member, NHMRC Australia Council; Editorial Board Member, Heart Asia, British Medical Journal; Member, The University of Western Australia, Forrest Foundation Selection Committee; Member, WA Health Translation Network (WAHTN) Executive Board
  • Since 2014 - Member, Association of Australian Medical Research Institutes (AAMRI) Board; Member, Australian Academy of Health and Medical Sciences (AAHMS) Finance Committee; Member, Australian Indigenous Doctors’ Association (AIDA); Member, Department of Corrective Services WA, Youth Justice Board; Member, CSL Young Florey Medical Selection Committee; Chair, Australian Academy of Health and Medical Sciences (AAHMS) Selection Committee 12; Member, Australian Academy of Health and Medical Sciences (AAHMS) Council
  • Since 2013-  Member, Western Australian Immunisation Strategy Implementation Steering    Committee (WAISISC); Chair, Clinical Advisory Group, WA RHD Control Program
  • Since 2012- Member, Western Australian State Health Research Advisory Council (SHRAC); Executive Director, Telethon Kids Institute Board of Directors; Member, Australian Institute of Company Directors; Member, Program Management Committee, RHD Australia
  • Since 2011- Editorial Board Member, Global Heart Journal, World Heart Federation and Elsevier; Working Group on Rheumatic Fever and Rheumatic Heart Disease, World Heart Federation, Geneva
  • Since 2010- Board Member, One Disease at a Time Foundation
  • Since 2008- Expert Group Core Member and Head, Expert Group on Rheumatic Heart Disease, Cardiovascular Diseases Expert Group, Global Burden of Diseases, Injuries, and Risk Factors Study
  • Since 2007-  National Committee for Medicine, Australian Academy of Science.
  • Currently CI on three NHMRC CREs (CIA # 1080401; CIB on # 102170, CII on #1110341), three NHMRC Project Grants (CIA on # 1027040, CIF#1098319, CIC #1099183), a Co-principal investigator on an NHMRC & NZ Health Research Council grant and a CI on the NHMRC Targeted Call for Research (TCR) Grant (#1113531) in genomics medicine.
  • 2016-20: NHMRC Targeted Call for Research Grant 1113531. Preparing Australia for genomics medicine: A proposal by the Australian Genomics Health Alliance.  Chief Investigators:  K North,…, J Carapetis, et al.  $25,000,000.
  • 2016-20: NHMRC Research Grant 1110341. Centre of Research Excellence in reducing the effects of antenatal alcohol on child health (REAACH). Chief Investigators:  C Bower, E Elliott, J Fitzpatrick, R Watkins, H D’Antoine, J Oscar, R Giglia, S Zubrick, J Carapetis. $2,497,397.
  • 2016-20: NHMRC Project Grant 1098319. Optimising intervention strategies to reduce  the burden of Group A Streptococcus in Aboriginal Communities, S Tong, J McVernon, R Andrews, N Geard, R Dhurrkay, J Carapetis, B Currie, A Steer, P Giffard, A Bowen. $856,896.
  • 2016-20: NHMRC Project Grant 1099183. Group A streptococcal human challenge study: accelerating vaccine development, A Steer, M Batzloff, J Carapetis, P Smeesters, C Waddington, M Pandey, J Dale, T Schuster. $2,018,741.
  • 2016-17: AusTrade Commonwealth Grant Agreement ATMC50298. Towards a new long-acting penicillin formulation for rheumatic fever. J Carapetis. $223,134 | Novartis Institutes for BioMedical Research, Inc $175,234 | Wesfarmers Centre of Vaccines and Infectious Diseases $47,900.
  • 2015-19: NHMRC Research Grant 1080401. Centre of Research Excellence in developing an endgame for rheumatic heart disease in Australia.  Chief Investigators: J Carapetis, B Currie, G Maguire, D Bessarab, D McAullay, H D’Antoine, A Brown, K Edmond, A Street, N de Klerk.  $2,500,000.
Ingrid Scheffer

Professor
Ingrid
Scheffer AO

Professor Scheffer is a paediatric neurologist and professor at the University of Melbourne and Florey Institute of Neuroscience and Mental Health. Professor Scheffer is helping to transform the diagnosis and treatment of epilepsy. She is a founding fellow of the Australian Academy of Health and Medical Sciences and currently its Vice-President.

Declaration

  • Member of Editorial Board (Journals, no funding): Epileptic Disorders, Neurology, Epilepsy Currents, Progress in Epileptic Disorders Series
  • Has received funding for travel from: UCB, Athena Diagnostics, GlaxoSmithKline, Sanofi, Weizmann Institute, Ramaciotti Foundation, International League Against Epilepsy, Australian Academy of Science, Perpetual Charitable Trustees Has also received funding for travel from various universities, hospitals and associations
  • Has received honoraria/payment for lectures from: UCB, Eisai, Athena Diagnostics, Transgenomics, GlaxoSmithKline
  • Has received revenue for patent: Diagnostic and therapeutic methods for EFMR (WO/2009/08659)
  • Has received the following grants: HMRC Program Grant #628952 CI 2011-2015, 2016-2020 NHMRC Project Grant 2013-2015, 2016-2020 NIH Centre Without Walls funding "Epi4K" 2011-2015 The Tasmanian Infantile Epileptic Encephalopathy Project 2013-2015 Murdoch Childrens Research Institute Population Health Theme Funding 2015 March of Dimes Foundation 2015-17 Health Research Council of New Zealand 2015-18
  • Has received the following grants: NHMRC Practitioner Fellowship 2011-2015, 2016-2020
  • As part of my position within the International League Against Epilepsy I have created submissions relating to the classification of the epilepsies I am a member of the Victorian Law Reform Commission Medical Advisory Committee on Medicinal Cannabis
  • Has published translational work for families with individuals with epilepsy: Nation J, Cross H, Scheffer IE. Ketocooking: A practical guide to the ketogenic diet. The Homewood Press, UK 2012 Relevant publications: Berg AT, Berkovic SF, Brodie MJ, Buchhalter K, Cross JH, van Emde Boas W, Engel J, French K, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51:676-85. Epub 2010 Feb 26. Scheffer IE, Berg AT. Classification and clinical features of absence epilepsies: how evidence leads to changing concepts. Epilepsia 2008;49:2140-1 (invited commentary). Korff CM, Scheffer IE. Epilepsy classification – a cycle of evolution and revolution. Curr Opin Neurol 2013;26:163-7 (invited review). Scheffer IE. Epilepsy: a classification for all seasons? Epilepsia 2012;53(Suppl 2):6-9 (invited commentary). Berg AT, Scheffer IE. What is at stake in a classification? Epilepsia 2011;52:1205-8 (invited commentary). Berg A, Scheffer IE. New concepts in classification of the epilepsies: entering the 21st century. Epilepsia 2011;52:1058-62. (invited commentary)
  • Is a member of the following associations: International League Against Epilepsy - Chair, ILAE Classification Taskforce; ILAE Seizure Taskforce; ILAE Syndromes and Diagnostic Manual Taskforce Epilepsy Society of Australia International Child Neurology Association (member of research & nominating committee) Australian Epilepsy Clinical Trials Network Executive Committee L'Oreal For Women in Science Fellowships Committee Australian Academy of Science - Sectional Committee 12: Medicine and Public Health Australian Academy of Health and Medical Sciences Founding Vice-President and Fellow Twitter: @ingridscheffer Website: www.ingridscheffer.com(link is external)
  • Clinical Trials conducted with: UCB, Zogenix, Ultragenyx, INSYS
  • Member of Scientific Advisory Committee, The Clive and Vera Ramaciotti Foundation 2013-2015
  • GlaxoSmithKline Award for Research Excellence
  • Has given over 450 lectures (international and national) for various associations, universities and hospitals. Has given lectures for Eisai, GSK, Transgenomics, Sanofi, GlaxoSmithKline
Elizabeth Sullivan

Professor
Elizabeth
Sullivan

Professor Sullivan is a public health physician, medical epidemiologist and health services researcher. She is Assistant Deputy Vice Chancellor (Research) and Professor of Public Health, University of Technology Sydney. Her research focuses on vulnerable reproductive populations, surveillance systems, justice health and health inequality among mothers and the impact on their infants.

Previous positions include Professor of Perinatal and Reproductive Health and Director, AIHW National Perinatal Epidemiology and Statistics Unit, University of New South Wales, and Head of Research, Family Planning NSW.

Declaration

  • Has received the following grants: NHMRC Project Grants (APP1109009, 2016-2018); (APP11088115, 2016-2020); (APP1078444, 2014-2018);(APP 1043693, 2013-2016); (APP1024206, 2012-2016);  (APP630653, 2010-2016); NHMRC Partnership Project (APP1028554, 2012-2016).   Has received funding from the Heart Foundation NSW CVRN Women and Heart Disease Grant. 2017-2019
  • Member, Obstetric Clinical Committee of the Medicare Benefits Schedule (MBS) Review Taskforce ; Member, Gynaecology Clinical Committee of the Medicare Benefits (MBS) Review Taskforce